A Pilot Study to Evaluate the Efficacy and Safety of NaviFUS™ System Neuromodulating Treatment for Patients With Drug Resistant Epilepsy

Clinical trial NCT06492720 · RECRUITING

Trial details

NCT number: NCT06492720
Sponsor: NaviFUS Corporation
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Drug Resistant Epilepsy Epilepsy Epilepsy, Temporal Lobe Seizures, Focal

Start date: 2024-09-01
Primary completion: 2026-12-31
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.